Geode Capital Management, LLC Sangamo Therapeutics, Inc Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,138,309 shares of SGMO stock, worth $5.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,138,309
Previous 1,866,186 14.58%
Holding current value
$5.22 Million
Previous $671,000 173.92%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$0.32 - $1.1 $87,079 - $299,335
272,123 Added 14.58%
2,138,309 $1.84 Million
Q2 2024

Aug 09, 2024
SELL
$0.36 - $0.65 $539,137 - $973,443
-1,497,605 Reduced 44.52%
1,866,186 $671,000
Q1 2024

May 13, 2024
BUY
$0.42 - $1.38 $66,142 - $217,323
157,481 Added 4.91%
3,363,791 $2.25 Million
Q4 2023

Feb 13, 2024
BUY
$0.3 - $0.63 $62,515 - $131,281
208,384 Added 6.95%
3,206,310 $1.73 Million
Q3 2023

Nov 13, 2023
BUY
$0.58 - $1.47 $82,460 - $208,995
142,174 Added 4.98%
2,997,926 $1.8 Million
Q2 2023

Aug 11, 2023
BUY
$1.11 - $1.74 $295,727 - $463,572
266,421 Added 10.29%
2,855,752 $3.71 Million
Q1 2023

May 15, 2023
BUY
$1.66 - $3.67 $156,803 - $346,668
94,460 Added 3.79%
2,589,331 $4.56 Million
Q4 2022

Feb 13, 2023
BUY
$2.77 - $5.07 $311,447 - $570,050
112,436 Added 4.72%
2,494,871 $7.83 Million
Q3 2022

Nov 14, 2022
BUY
$4.27 - $6.39 $911,311 - $1.36 Million
213,422 Added 9.84%
2,382,435 $11.7 Million
Q2 2022

Aug 12, 2022
BUY
$3.28 - $6.21 $251,385 - $475,946
76,642 Added 3.66%
2,169,013 $8.98 Million
Q1 2022

May 13, 2022
SELL
$5.23 - $7.82 $715,526 - $1.07 Million
-136,812 Reduced 6.14%
2,092,371 $12.2 Million
Q4 2021

Feb 11, 2022
BUY
$7.29 - $10.97 $246,693 - $371,224
33,840 Added 1.54%
2,229,183 $16.7 Million
Q3 2021

Nov 12, 2021
BUY
$9.01 - $12.01 $1.21 Million - $1.62 Million
134,807 Added 6.54%
2,195,343 $19.8 Million
Q2 2021

Aug 13, 2021
BUY
$10.17 - $12.64 $819,457 - $1.02 Million
80,576 Added 4.07%
2,060,536 $24.7 Million
Q1 2021

May 12, 2021
BUY
$10.88 - $17.05 $1.8 Million - $2.82 Million
165,123 Added 9.1%
1,979,960 $24.8 Million
Q4 2020

Feb 12, 2021
BUY
$9.23 - $18.18 $516,907 - $1.02 Million
56,003 Added 3.18%
1,814,837 $28.3 Million
Q3 2020

Nov 13, 2020
SELL
$9.38 - $12.48 $128,205 - $170,576
-13,668 Reduced 0.77%
1,758,834 $16.6 Million
Q2 2020

Aug 13, 2020
BUY
$6.21 - $11.83 $518,392 - $987,532
83,477 Added 4.94%
1,772,502 $15.9 Million
Q1 2020

May 14, 2020
BUY
$5.05 - $8.85 $527,502 - $924,435
104,456 Added 6.59%
1,689,025 $10.8 Million
Q4 2019

Feb 13, 2020
BUY
$8.03 - $11.7 $414,356 - $603,731
51,601 Added 3.37%
1,584,569 $13.3 Million
Q3 2019

Nov 12, 2019
BUY
$9.05 - $12.22 $423,702 - $572,115
46,818 Added 3.15%
1,532,968 $13.9 Million
Q2 2019

Aug 14, 2019
BUY
$8.75 - $13.03 $2.04 Million - $3.04 Million
233,677 Added 18.66%
1,486,150 $16 Million
Q1 2019

May 14, 2019
BUY
$7.72 - $12.81 $950,393 - $1.58 Million
123,108 Added 10.9%
1,252,473 $11.9 Million
Q4 2018

Feb 13, 2019
BUY
$9.51 - $16.6 $149,782 - $261,450
15,750 Added 1.41%
1,129,365 $13 Million
Q3 2018

Nov 13, 2018
BUY
$13.05 - $19.05 $418,213 - $610,495
32,047 Added 2.96%
1,113,615 $18.9 Million
Q2 2018

Aug 14, 2018
BUY
$13.9 - $19.8 $3.39 Million - $4.82 Million
243,573 Added 29.07%
1,081,568 $15.4 Million
Q1 2018

May 15, 2018
SELL
$16.7 - $26.35 $35,220 - $55,572
-2,109 Reduced 0.25%
837,995 $15.9 Million
Q4 2017

Feb 13, 2018
BUY
$11.6 - $17.35 $221,409 - $331,159
19,087 Added 2.32%
840,104 $13.8 Million
Q3 2017

Nov 14, 2017
BUY
$8.4 - $15.0 $784,576 - $1.4 Million
93,402 Added 12.84%
821,017 $12.3 Million
Q2 2017

Aug 14, 2017
BUY
N/A
727,615
727,615 $6.4 Million

Others Institutions Holding SGMO

# of Institutions
114
Shares Held
57.4M
Call Options Held
560K
Put Options Held
1.15M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $382M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email